
ABOUT THE AUTHOR
Tobias Renner
Tobias Renner is a medical journalist with an epidemiology background and eight years covering health policy, FDA calendars, and clinical milestones. At Trade Engine Tobias runs the Health Round Power-Up, a quick-scan digest that turns trial readouts, safety updates, and reimbursement decisions into actionable takeaways. Expect clear context on endpoints, study design, and addressable market without the jargon that slows investors down. Tobias has contributed to healthcare newsletters and appears on live briefings during major conferences, where speed and accuracy matter most. His roundups prioritize what can move timelines, label language, and revenue ramps in the near term. Away from the keyboard he is a habitual time-splitter who measures everything with a stopwatch, from jogs to docket refreshes, to keep the cadence tight for readers.
LATEST ARTICLES


COP30 Deadlock Over Fossil Fuel Phase-Out Raises Questions for Oil, Power and Renewables Markets
Tobias Renner
November 17, 2025 12:02 PM
Read More »

New diabetes heart-drug trial and C-section anesthesia study reshape clinical and market signals
Tobias Renner
November 13, 2025 5:32 PM
Read More »

IEA Sees Rising Oil Demand to 2050 as Chevron Doubles Down on Production
Tobias Renner
November 13, 2025 12:02 PM
Read More »

Advanced diagnostics redraw care pathways for heart and kidney patients
Tobias Renner
November 11, 2025 5:51 PM
Read More »

Antibiotic link to lower schizophrenia risk and melatonin heart warning hit pharma markets
Tobias Renner
November 6, 2025 1:59 PM
Read More »

Oil Storage, Near‑record LNG Deals and a Lukoil Sale That Could Reshape Trade Flows
Tobias Renner
November 6, 2025 12:03 PM
Read More »

Shock wave therapy, viral infection risks and what health markets should watch now
Tobias Renner
November 4, 2025 7:31 PM
Read More »

OPEC+ Pause, Record U.S. Output and China’s EV Boom Recast Global Oil and Gas Flows
Tobias Renner
November 3, 2025 12:02 PM
Read More »

Three new infection-fighting breakthroughs that could reshape treatment and industry priorities
Tobias Renner
October 30, 2025 4:36 PM
Read More »
THE LATEST
Russia’s central bank boosts gold operations as liquidity and markets react
Clara Winslow
November 19, 2025 10:03 AM
Stocks to Watch at the Open: Agios Sinks as Dycom, Modine and Lumentum Outperform
Miles Harrow
November 19, 2025 10:01 AM
Markets Face a News-Heavy Session as Chip Results, Rare Earth Shortages and Political Shocks Collide
Ethan Vale
November 19, 2025 7:02 AM
AI trade jitters and softer consumer demand push markets lower ahead of Nvidia earnings
Caleb Thorne
November 18, 2025 6:12 PM
Markets Eye Small-Biz Weakness and $2,000 Tariff Checks as Rate Cut Talk Grows
Caleb Thorne
November 18, 2025 12:01 PM
Bank of England Plans Major Cut to QE Gilt Holdings, Markets Reassess Policy Risk
Clara Winslow
November 18, 2025 10:02 AM
Risk appetite slides as U.S. consumer worries and China deflation weigh on markets
Ethan Vale
November 17, 2025 5:02 PM
Market Close: Crocs, Lucid and Dell Among Today’s Biggest Movers
Miles Harrow
November 17, 2025 4:16 PM
Tariff Shock and Fed Watch Set Tone for U.S. Trading Session
Caleb Thorne
November 17, 2025 12:02 PM
IMF Opens New Loan Talks with Ukraine as Corruption Probe Tests Kyiv’s Credibility
Clara Winslow
November 17, 2025 10:03 AM
ABOUT US
PRIVACY POLICY
TERMS AND CONDITIONS
- ALTERNATIVE INVESTING
- COMMUNICATION SERVICES
- CONSUMER DISCRETIONARY
- CORPORATE NEWS
- ECONOMY
- EDITOR’S CHOICE
- ENERGY
- ENERGY & INDUSTRIALS
- FINANCIAL NEWS
- FINANCIAL SECTOR
- HEALTHCARE SECTOR
- INDUSTRIALS
- MARKET UPDATE
- POINT OF ENTRY
- POLITICS
- PRE-MARKET REPORT
- RESOURCE STOCKS
- STOCK SPOTLIGHT
- STOCKS TO WATCH
- TECH SECTOR TRENDS
- TECHNOLOGY
- UP AND COMING STOCKS
- UTILITIES










